DxUpClose, Inc. is developing a medical device that is a small, light weight, portable bacterial diagnostic that is designed to perform an antibiotic susceptibility test in sixty minutes in a doctor's office.
At the end of the test, the product will securely send to the physician's email or smartphone a list of antibiotics tested and that are effective against the bacteria in the patient's sample. Results can be rapidly interpreted by a physician who can then either write a prescription or ePrescribe the appropriate antibiotic. This will reduce the delay in optimal patient care present today by 24 to 72 hours.
The ability to determine effective antibiotics within sixty minutes will give physicians a chance to change the way they practice medicine, provide better healthcare and reduce the number of antibiotic resistant bacteria in the world. While providing better care, they will be able to create a new revenue stream for themselves. Other customers targeted by our product are extended stay facilities and home healthcare service providers who will also be able to create new revenue streams.
When patients return to hospitals with infections within thirty days of release, payors don't usually reimburse the re-admission. This causes hospitals to follow their patients after they are released to home healthcare or extended stay facilities. By detecting infections while they can still be treated as outpatients, hospitals will increase their margins.
Using a reoccurring revenue model, DxUpClose, Inc. plans to expand our product portfolio, over time, across a wide range of infectious diseases and their associated antimicrobial therapeutics.
DxUpClose has an ongoing relationship with Emergency Service Partners (ESP), who staff Seton Healthcare Network emergency rooms in Texas. Seton is a healthcare provider serving rural Texas, which includes hospitals, clinics and extended stay facilities. Seton is part of Ascension Health, who command 1% of all healthcare dollars spent in the US.
Our core technology is based on electronic sensors and is covered by an issued patent which is supported by other patents. We have a functional electronic prototype and are continuing product development at this time.